These findings support the hypothesis that TRPM7 is closely related to systemic symptoms, organ dysfunction and mortality during endotoxemia, suggesting that this channel could be a good target for the treatment of endotoxemia, sepsis and other inflammatory diseases. The gene discussed is TRPM7; the disease is serum lipopolysaccharide activity.